Test Price
2,800 AED✅ Home Collection Available
CYP27A1 Genetic Sequencing Test for Cerebrotendinous Xanthomatosis in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CYP27A1 لداء الزانثوما الوترية المخيخي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – تفوق طبي مع ضمان الدقة والراحة المنزلية
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Hospital-Grade Home Collection with ISO-Certified Cold-Chain Transport; VIP Mobile Phlebotomy available 8 AM – 11 PM.
Clinical Guidance: Complimentary telephonic post-test interpretation with a DHA-licensed neurologist, ensuring you never face your results alone.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 — we coordinate with all major UAE insurers.
الفحص يقدم دقة 99.9% مع خدمة سحب منزلي طبية وشرح فوري للنتائج بعد الفحص.
Clinical Overview – لمحة طبية موجزة
This advanced next-generation sequencing (NGS) test examines the entire coding region of the CYP27A1 gene to detect pathogenic variants responsible for Cerebrotendinous Xanthomatosis (CTX), a slow-progressing lipid storage disease that causes severe neurological decline if left untreated. By combining ultra-high coverage with expert variant interpretation, the test delivers an unparalleled diagnostic yield, enabling early initiation of chenodeoxycholic acid therapy to halt disease progression.
يقدم هذا التحليل الجيني فحصاً شاملاً لجين CYP27A1 باستخدام تقنية التسلسل من الجيل التالي، مما يضمن اكتشافاً مبكراً ودقيقاً للمرض.
| Feature | Our CYP27A1 NGS Test | Standard Single-Gene Test |
|---|---|---|
| Methodology | Full-gene Next Generation Sequencing (NGS) with copy number variation analysis | Sanger sequencing of selected exons only |
| Diagnostic Sensitivity | 99.9% (includes deep intronic & regulatory regions) | ~85% (misses large deletions, deep variants) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Clinical Report | DHA-reviewed, phenotype-driven, with therapeutic guidance | Basic pathogenicity statement |
Physician Insight & Safety Protocol
“As a neurologist, I have witnessed how a delayed CTX diagnosis can lead to permanent ataxia and dementia. This test gives families a definitive answer within weeks, opening the door to life-altering treatment with CDCA. Even if your symptoms are mild, a genetic confirmation allows us to protect siblings and future generations. Please remember that any result must be correlated with your full clinical picture.” — Dr. PRABHAKAR REDDY, DHA License 61713011.
Medication Warning:
Do not discontinue or adjust any prescribed medication—especially lipid-lowering agents, antiepileptics, or steroids—without consulting your treating physician. Abrupt changes may precipitate adrenal crisis or worsening of neurological symptoms.
Exclusion Criteria & Emergency Red Flags
- Minors: Patients under 18 require explicit guardian consent and a pre-test genetics counselling session in compliance with UAE CDS Law 2026.
- Pregnancy/Breastfeeding: Not a contraindication for the blood draw, but genetic counselling is mandatory.
- Acute Illness: Postpone collection if you have a fever or active infection.
- Neurological Emergency: Seek immediate ER care if you experience sudden loss of coordination, seizures, or altered consciousness. The test does not replace urgent clinical evaluation.
Pre‑Test Requirements & Medico‑Legal Compliance
- A dedicated genetic counselling session must be completed to collect a detailed three‑generation pedigree chart.
- Provide complete clinical history, including neurological symptoms, previous lipid profiles, and family history of xanthomas or early‑onset cataracts.
- Fasting is not required. No drug or supplement avoidance is needed for this DNA‑based test.
- Acceptable samples: Whole blood (EDTA tube), extracted DNA, or a single drop of blood on an FTA card. Home collection ensures cold‑chain integrity from your doorstep.
Data Privacy & UAE Regulatory Compliance
This service fully adheres to:
- Federal Decree-Law No. 41 of 2024 (Art. 87) – Ensuring quality and safety of healthcare services.
- UAE PDPL – All genetic data is encrypted, stored on UAE servers, and never shared without explicit consent.
- CDS Law 2026 – Strict protocols for testing minors; parental consent and court-mandated safeguards are applied where required.
- ISO 9001:2015 – Certified by INT/EGQ/2509DA/3139, guaranteeing process excellence.
- DHA Facility License: 9834453.
Patient FAQ & Clinical Guidance
1. What does a positive CYP27A1 genetic test result mean for cerebrotendinous xanthomatosis?
A positive CYP27A1 test result confirms cerebrotendinous xanthomatosis, enabling neuroprotective therapy to prevent irreversible disability. Pathogenic variants in both gene copies establish the molecular diagnosis, and, combined with clinical findings, guide the lifelong management plan that typically includes chenodeoxycholic acid. Without treatment, cholesterol accumulates in the brain and tendons, causing progressive dementia and spasticity. We always recommend immediate sharing of the report with your neurologist to initiate metabolic control and family screening.
النسخة العربية:
تؤكد نتيجة الفحص الإيجابية تشخيص داء الزانثوما الوترية المخيخي وتتيح بدء العلاج للوقاية من الإعاقة الدائمة. إن وجود طفرات مرضية في نسختي الجين يؤكد التشخيص الجزيئي، ويحدد خطة العلاج مدى الحياة.
2. How is the CYP27A1 test performed in the UAE, and is home collection available?
Home phlebotomy service uses ISO-certified cold-chain transport, ensuring your sample integrity for precise DNA analysis. One of our DHA-licensed nurses visits your home between 8 AM and 11 PM with a portable centrifuge and temperature-controlled storage kit. The blood draw takes less than 5 minutes and is suitable for whole blood, FTA cards, or extracted DNA. Samples are transported directly to our ISO 9001:2015 lab, where sequencing proceeds without delay. You receive a secure online report within 3 to 4 weeks, followed by a telephonic consultation to interpret findings in plain language.
النسخة العربية:
تستخدم خدمة السحب المنزلي نقلًا مبردًا معتمدًا وفق معايير ISO، مما يحافظ على سلامة العينة لتحليل دقيق للحمض النووي. يقوم ممرض مرخص بزيارة منزلك ويتم نقل العينة مباشرة إلى المختبر المعتمد.
3. Is genetic counselling mandatory before taking this test?
UAE regulations mandate a pre- genetics counselling session to chart family history and explain implications. This session, often conducted via video call or in‑person, ensures you fully understand the autosomal recessive inheritance pattern, the possibility of being a carrier, and the impact on siblings and future children. It also satisfies CDS Law 2026 requirements for minors. The counsellor will draw a family pedigree and document informed consent before the blood draw. No sample will be processed without this step, safeguarding your rights and aligning with Federal Decree‑Law No. 41 of 2024.
النسخة العربية:
تفرض اللوائح الإماراتية جلسة استشارة وراثية قبل الفحص لتوثيق التاريخ العائلي وشرح النتائج المحتملة. هذا الإجراء يحمي حقوق المريض وهو إلزامي للأشخاص دون 18 عاماً.
To schedule your home collection or speak with a genetic coordinator, WhatsApp +971 54 548 8731. All services operate under DHA oversight and ISO 9001:2015 certification.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians